Search results for “Liposarcoma” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 220 patents, we discovered top 33 key players by total patent application. Novartis AG, Daiichi Sankyo Co., Ltd., Novartis Pharma GmbH are dominant in this area. They take 70.91% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 130
Daiichi Sankyo Co., Ltd.
New Jersey, United States
Patent: 16
Novartis Pharma GmbH
Austria
Patent: 10
CEPTYR, Inc.
Washington, United States
Patent: 7
Smithkline Beecham Plc
United Kingdom
Patent: 5
GamaMabs Pharma SA
France
Patent: 5
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 4
Exelixis, Inc.
California, United States
Patent: 4
Falcon Technology Partners LP
Delaware, United States
Patent: 3
Incyte Corp.
Delaware, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
NantOmics LLC
California, United States
Patent: 1
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents applied in the last 5 years. We discover 22 most active companies in this area. The fast-growing Institut Curie, Daiichi Sankyo Co., Ltd., GamaMabs Pharma SA take 55.88% of patent filing during this period.
Institut Curie
France
Patent: 9
Daiichi Sankyo Co., Ltd.
New Jersey, United States
Patent: 5
GamaMabs Pharma SA
France
Patent: 5
Exelixis, Inc.
California, United States
Patent: 4
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 2
Nobelpharma Co., Ltd.
Tokyo-to, Japan
Patent: 1
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Academy of Military Medical Sciences
China
Patent: 1
Karyopharm Therapeutics, Inc.
Massachusetts, United States
Patent: 1
The Johns Hopkins University
United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents in last 5 years, we discover 18 new entrants. Institut Curie, GamaMabs Pharma SA, Exelixis, Inc. are the most active new entrants in this area.
Institut Curie
France
Patent: 9
GamaMabs Pharma SA
France
Patent: 5
Exelixis, Inc.
California, United States
Patent: 4
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 2
Nobelpharma Co., Ltd.
Tokyo-to, Japan
Patent: 1
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Academy of Military Medical Sciences
China
Patent: 1
Karyopharm Therapeutics, Inc.
Massachusetts, United States
Patent: 1
NantOmics LLC
California, United States
Patent: 1
Arizona Board of Regents
Arizona, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 51 patents, we discovered top 7 universities and scientific research institutions by total patent application. Georgetown University School of Medicine, The Johns Hopkins University, Duke University are dominant in this area. They take 54.90% of the total patent filing.
Georgetown University School of Medicine
District of Columbia, United States
Patent: 10
The Johns Hopkins University
United States
Patent: 9
Duke University
North Carolina, United States
Patent: 8
The Salk Institute for Biological Studies
California, United States
Patent: 4
Nankai University
Tianjin Shi, China
Patent: 2
Texas Tech University System
Texas, United States
Patent: 1
Academy of Military Medical Sciences
China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: